SCHEMBL28503565

SCHEMBL28503565

CCCCCCOc1ccc(Cc2nc(N)c3ccccc3n2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 2/20 0.52
▸ HTT P42858 1/20 0.52
▸ HSD17B10 Q99714 1/20 0.52
▸ PKM P14618 2/20 0.48
▸ ITGB1 P05556 1/20 0.47
▸ ITGA4 P13612 1/20 0.47
▸ TLR8 Q9NR97 4/20 0.46
▸ LTA4H P09960 1/20 0.46
▸ SMN1; SMN2 Q16637 2/20 0.45
▸ CYP1A2 P05177 1/20 0.45
▸ CYP3A4 P08684 1/20 0.45
▸ GAA P10253 1/20 0.45
▸ CYP2D6 P10635 1/20 0.45
▸ MAPT P10636 1/20 0.45
▸ CYP2C9 P11712 1/20 0.45
▸ HPGD P15428 1/20 0.45
▸ CYP2C19 P33261 1/20 0.45
▸ NPC1 O15118 1/20 0.45
▸ RAB9A P51151 1/20 0.45
▸ KMT2A Q03164 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28514142 1.00 LMNA (0.52) LMNAHTTHSD17B10PKMITGB1
SCHEMBL28515245 0.87 DHFR (0.58) TLR8DHFR
SCHEMBL28515228 0.87 DHFR (0.58) TLR8DHFR
SCHEMBL28521021 0.80 ITGB1 (0.46) LMNAHTTHSD17B10PKMITGB1
SCHEMBL28513286 0.80 ITGB1 (0.46) LMNAHTTHSD17B10PKMITGB1
SCHEMBL28906706 0.78 TLR8 (0.54) LMNATLR8CYP1A2CYP3A4MAPT
SCHEMBL28503550 0.78 TLR8 (0.54) LMNATLR8CYP1A2CYP3A4MAPT
SCHEMBL28504818 0.78 TLR8 (0.51) LMNAHSD17B10TLR8SMN1; SMN2CYP3A4
SCHEMBL28508187 0.78 TLR8 (0.48) LMNAHSD17B10TLR8CYP3A4GAA
SCHEMBL28189562 0.77 L3MBTL1 (0.58) HSD17B10SMN1; SMN2CYP1A2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108250142-B Amine compounds having anti-inflammatory, antifungal, antiparasitic and anticancer activity 维尔斯达医疗公司 2021-01-26 — — CN disclosed
Send feedback